Carbobenzoxy-l-alanyl-alanyl-asparagine

Carbobenzoxy-l-alanyl-alanyl-asparagine is a synthetic peptide compound featuring a protected tripeptide sequence composed of L-alanine, L-alanine, and L-asparagine, with an N-terminal carbobenzoxy (Cbz or Z) protecting group. As a structurally defined peptide intermediate, it plays a significant role in peptide chemistry, enabling researchers to investigate peptide assembly, structure-activity relationships, and enzymatic processing. The presence of the Cbz group provides stability during synthetic manipulations and facilitates selective deprotection strategies, making this molecule a valuable building block for both academic and industrial research settings.

Peptide synthesis: One of the primary applications for this protected tripeptide lies in solid-phase and solution-phase peptide synthesis. The Cbz group serves as a temporary N-terminal protecting group, allowing for sequential elongation of peptide chains without undesired side reactions at the amino terminus. Researchers utilize this intermediate to construct longer peptide sequences with precise control over chain assembly, facilitating the creation of custom peptides for biochemical assays, structural studies, or functional analysis.

Enzymatic substrate studies: Carbobenzoxy-l-alanyl-alanyl-asparagine is frequently employed as a model substrate in enzymology to investigate the specificity and catalytic mechanisms of peptidases and proteases. By incorporating defined peptide sequences and protective groups, scientists can monitor enzymatic cleavage events, characterize substrate preferences, and elucidate the roles of key amino acid residues in enzyme-substrate interactions. Such studies provide insight into enzyme function and inform the design of selective inhibitors or activity-based probes.

Peptide structure-activity relationship (SAR) analysis: The defined sequence and protection pattern of this tripeptide make it a useful tool for probing structure-activity relationships in peptide-based systems. By systematically modifying the peptide backbone or protective groups, researchers can assess the impact of sequence variations and chemical modifications on biological activity, binding affinity, or conformational stability. This approach supports rational peptide design and optimization in both fundamental research and applied development.

Analytical method development: The compound serves as a reference standard or calibration material in chromatographic and spectrometric methods used for peptide analysis. Its well-characterized structure and predictable physicochemical properties enable the validation of analytical protocols, such as HPLC or mass spectrometry, for peptide identification, purity assessment, and quantification. Employing such standards ensures accuracy and reproducibility in peptide research workflows.

Biochemical assay reagent: In addition to its role in synthesis and analysis, the protected tripeptide can function as a specialized reagent in biochemical assays designed to study peptide transport, uptake, or modification. Its stability and defined sequence allow for controlled experimentation in systems investigating peptide recognition, metabolism, or modification, thereby supporting a broad range of biochemical research objectives.

1. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

2. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

3. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

5. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics